Combination of rapamycin and trametinib extends mouse lifespan by about 30%, study finds

Researchers at the Max Planck Institute for Biology of Aging have discovered that the combination of the two cancer drugs, rapamycin and trametinib, significantly extends the lifespan of mice. The work has been published in Nature Aging.

Leave A Comment

Your email address will not be published. Required fields are marked *